Amgen Inc financial data

Symbol
AMGN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
One Amgen Center Drive, Thousand Oaks, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 3, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 214 % +10.2%
Quick Ratio 39.2 % +15.6%
Return On Equity 58.6 % -72.1%
Return On Assets 4.06 % -64.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 536 M shares +0.4%
Common Stock, Shares, Outstanding 536 M shares +0.39%
Entity Public Float 119 B USD -8.76%
Weighted Average Number of Shares Outstanding, Basic 536 M shares +0.38%
Weighted Average Number of Shares Outstanding, Diluted 536 M shares -0.37%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 29.5 B USD +12.8%
Costs and Expenses 22.6 B USD +31.2%
Operating Income (Loss) 6.97 B USD -22.5%
Nonoperating Income (Expense) 534 M USD -70%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 7.86 B USD +6.93%
Income Tax Expense (Benefit) 582 M USD -51.3%
Net Income (Loss) Attributable to Parent 3.76 B USD -52.5%
Earnings Per Share, Basic 7.03 USD/shares -52.5%
Earnings Per Share, Diluted 7 USD/shares -52.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.71 B USD -69.2%
Accounts Receivable, after Allowance for Credit Loss, Current 6.78 B USD +18.1%
Inventory, Net 8.72 B USD +74.1%
Other Assets, Current 2.82 B USD +17.8%
Assets, Current 28 B USD -37.3%
Property, Plant and Equipment, Net 6 B USD +9.93%
Operating Lease, Right-of-Use Asset 651 M USD +12.4%
Intangible Assets, Net (Excluding Goodwill) 31.4 B USD +104%
Goodwill 18.6 B USD +19.6%
Other Assets, Noncurrent 9.01 B USD +18%
Assets 93 B USD +4.8%
Accounts Payable, Current 1.63 B USD +23.3%
Employee-related Liabilities, Current 1.38 B USD +25.7%
Accrued Liabilities, Current 14.1 B USD +17.1%
Liabilities, Current 19.7 B USD +38.7%
Deferred Income Tax Liabilities, Net 1.86 B USD
Operating Lease, Liability, Noncurrent 691 M USD +28.2%
Other Liabilities, Noncurrent 2.36 B USD -6.91%
Common Stocks, Including Additional Paid in Capital 33.1 B USD +1.68%
Accumulated Other Comprehensive Income (Loss), Net of Tax -190 M USD +29.1%
Retained Earnings (Accumulated Deficit) -27.9 B USD -3.53%
Stockholders' Equity Attributable to Parent 5.02 B USD -6.1%
Liabilities and Equity 93 B USD +4.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 689 M USD -35.2%
Net Cash Provided by (Used in) Financing Activities -1.71 B USD -108%
Net Cash Provided by (Used in) Investing Activities -217 M USD -116%
Common Stock, Shares Authorized 2.75 B shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.24 B USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.71 B USD -69.2%
Deferred Tax Assets, Valuation Allowance 957 M USD +33.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 5.51 B USD +55.8%
Operating Lease, Liability 810 M USD +16.5%
Depreciation 685 M USD +3.63%
Payments to Acquire Property, Plant, and Equipment 230 M USD -33.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3.84 B USD -54.3%
Lessee, Operating Lease, Liability, to be Paid 977 M USD +25.1%
Property, Plant and Equipment, Gross 15.7 B USD +7.06%
Operating Lease, Liability, Current 119 M USD -23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 121 M USD +11%
Lessee, Operating Lease, Liability, to be Paid, Year One 138 M USD -19.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +37%
Deferred Income Tax Expense (Benefit) -1.22 B USD +4.71%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 167 M USD +94.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 109 M USD +36.3%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -1.12 B USD +5.15%
Current Income Tax Expense (Benefit) 2.35 B USD +13.7%
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 4.01 B USD +6.42%
Lessee, Operating Lease, Liability, to be Paid, Year Four 95 M USD +35.7%
Operating Lease, Payments 182 M USD +6.43%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 43 M USD -2.27%
Current Federal Tax Expense (Benefit) 1.52 B USD -11.4%
Amortization of Intangible Assets 3.71 B USD +39.6%
Depreciation, Depletion and Amortization 1.4 B USD +55.4%
Deferred Tax Assets, Net of Valuation Allowance 4.55 B USD +61.5%
Share-based Payment Arrangement, Expense 473 M USD +18%
Deferred State and Local Income Tax Expense (Benefit) -25 M USD +7.41%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%